Skip to content

ScienceNot yet confirmed elsewhere1 publisher3 min readPublished

Hegemann, Nagel and Deisseroth share the medicine Nobel for switching neurons on with light

Peter Hegemann, Georg Nagel and Karl Deisseroth won this year's medicine Nobel for optogenetics, which uses light to switch on chosen neurons. With it, researchers can switch on one circuit and see whether a behavior follows, a direct test of cause.

The Scientist · Science desk

How we use AISend a correction

Photograph accompanying Hegemann, Nagel and Deisseroth share the medicine Nobel for switching neurons on with light
Photo: acs.org

What happened

  • In the early 2000s, Hegemann and Nagel found a protein in the eye spot of the green alga Chlamydomonas that produces an electrical impulse when lit, letting the cell move.
  • That protein, channelrhodopsin, opens like a pore under light, so positively charged ions flow into the cell.
  • Science News frames the physics prize around IceCube, a cubic kilometer of ice under the South Pole threaded with thousands of beadlike sensors that detect neutrinos.

Why it matters

  • constraint Every use of the switch needs both a gene and a light source inside the target tissue; in the founding mouse work, the light arrived through optical fibers fed through the skull.
  • constraint For depression and dementia the stated payoff is research 'implications', and a whisker moved in a mouse is a long way from a treatment in a person.
  • capability Neutrinos caught from beyond the solar system give physicists a way to study where and how the universe accelerates particles to extraordinary energies.

Science News puts the human brain at nearly 90 billion neurons joined by some 100 trillion connections [4]. That works out to roughly 1,100 connections per neuron on average [22]. Linking one behavior to one circuit inside that network takes a tool that can pick out specific cells. Abdel El Manira, a neuroscientist at the Karolinska Institute in Stockholm, described what the field wanted at the Oct. 5 announcement by the Nobel Assembly at Karolinska Institute [14][1]. "Neuroscientists dreamed of a neuronal switch, a tool to turn specific neurons on or off with great precision," he said [5].

The prize goes to biophysicists Peter Hegemann of Humboldt University in Berlin and Georg Nagel, and to Stanford neuroscientist Karl Deisseroth [2]. Their field, optogenetics, uses light to activate chosen cells and then watches how behavior changes [3]. The switch came out of basic work on an alga's eye spot [6]. "They had just discovered the switch neuroscientists had long dreamed of," El Manira said [8].

Deisseroth's experiments ran in two stages, and I like the design because each stage answered its own question. His group first put the channelrhodopsin gene into cultures of rat nerve cells, and the cells reacted to light instantaneously [9]. That showed a protein from an alga could drive mammalian neurons in a dish. Only then did the team move to living mice, adding the gene to brain cells and running optical fibers through the skull to carry blue light in [10].

The whisker result is an intervention. Recording which neurons fire while an animal moves shows two things happening together. Turning a defined circuit on and watching the whisker move tests whether the circuit drives the movement, and Science News says this is the ability the technology gave researchers [21]. "The technology, which soon became known as optogenetics, transformed neuroscience," El Manira said [11].

He added that the method "has also helped reveal how brain circuits are disrupted, with implications for conditions such as blindness, depression and dementia" [12]. The clinical example Science News gives is improved vision in some patients with retinitis pigmentosa, a disease that degrades the retina's light-sensing cells [13]. The article does not say how many patients were treated or how much their sight improved. The founding demonstration was in mice. For depression and dementia, the word El Manira used was implications [12].

The physics prize, in Science News's account, is for detecting an ultra-elusive subatomic particle from beyond the solar system [15]. That particle is the neutrino, and catching neutrinos from outside the solar system had been a goal of scientists for decades [17]. Science News credits physicist Francis Halzen with leading the creation of IceCube, the Antarctic observatory built to do it [19].

Science News describes the chemistry prize as a solution to "one of the most enduring puzzles in all of organic chemistry" [20].

What to watch

  • The full Nobel citations for physics and chemistry, which would spell out exactly which neutrino detection and which organic chemistry puzzle the committees honored.
  • Published patient counts and effect sizes for optogenetic vision restoration in retinitis pigmentosa, the one human result Science News cites.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence62
Adoption
Insufficient
Hype gap+10
Incentives
Insufficient
Confidence62
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    The Nobel Assembly at Karolinska Institute announced this year's prize in physiology or medicine on Oct. 5.

    ReportedSupportedView cited source
  2. [2]

    Biophysicists Peter Hegemann of Humboldt University in Berlin and Georg Nagel of the Julius-Maximilians-Universitat Wurzburg in Germany, and neuroscientist Karl Deisseroth of Stanford University, shared this year's prize in physiology or medicine for their foundational contributions to optogenetics.

    ReportedSupportedView cited source
  3. [3]

    Optogenetics involves using light to precisely activate specific cells, like neurons, and watch how behavior changes.

    ReportedSupportedView cited source

Sources

1 independent publisher whose own reporting we read for this story.

  1. sciencenews.org

    1 article · October 9, 2026

    Here’s a look at the Nobel Prizes for science

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Entities

Loading related stories